Literature DB >> 31348975

Novel insights into breast cancer progression and metastasis: A multidisciplinary opportunity to transition from biology to clinical oncology.

Manuel Scimeca1, Nicoletta Urbano2, Rita Bonfiglio3, Andrea Duggento4, Nicola Toschi5, Orazio Schillaci6, Elena Bonanno7.   

Abstract

According to the most recent epidemiological studies, breast cancer shows the highest incidence and the second leading cause of death in women. Cancer progression and metastasis are the main events related to poor survival of breast cancer patients. This can be explained by the presence of highly resistant to chemo- and radiotherapy stem cells in many breast tumor tissues. In this context, numerous studies highlighted the possible involvement of epithelial to mesenchymal transition phenomenon as biological program to generate cancer stem cells, and thus participate to both metastatic and drug resistance process. Therefore, the comprehension of mechanisms (both cellular and molecular) involved in breast cancer occurrence and progression can lay the foundation for the development of new diagnostic and therapeutical protocols. In this review, we reported the most important findings in the field of breast cancer highlighting the most recent data concerning breast tumor biology, diagnosis and therapy.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Artificial intelligence; BCSCs; Breast cancer; EMT; Molecular imaging; Personalized medicine; Therapy

Mesh:

Substances:

Year:  2019        PMID: 31348975     DOI: 10.1016/j.bbcan.2019.07.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  12 in total

1.  Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer.

Authors:  Jennifer R Diamond; Carlos Becerra; Donald Richards; Alain Mita; Cynthia Osborne; Joyce O'Shaughnessy; Chun Zhang; Randall Henner; Ann M Kapoun; Lu Xu; Bob Stagg; Shailaja Uttamsingh; Rainer K Brachmann; Azeez Farooki; Monica Mita
Journal:  Breast Cancer Res Treat       Date:  2020-08-14       Impact factor: 4.872

2.  Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer.

Authors:  Xin Tian; Lina Wu; Min Jiang; Zhenyong Zhang; Rong Wu; Jianing Miao; Caigang Liu; Song Gao
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 5.738

3.  Possible involvement of TGF‑β‑SMAD‑mediated epithelial‑mesenchymal transition in pro‑metastatic property of PAX6.

Authors:  Meng Jin; Daili Gao; Rongchun Wang; Attila Sik; Kechun Liu
Journal:  Oncol Rep       Date:  2020-06-11       Impact factor: 3.906

4.  Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells.

Authors:  Fang Huang; Jinjin Zhao; Yiting Wei; Zhifa Wen; Yue Zhang; Xuru Wang; Yanfei Shen; Li-Xin Wang; Ning Pan
Journal:  Int J Nanomedicine       Date:  2020-02-13

5.  18F-Choline PET/CT Identifies High-Grade Prostate Cancer Lesions Expressing Bone Biomarkers.

Authors:  Nicoletta Urbano; Manuel Scimeca; Antonio Crocco; Alessandro Mauriello; Elena Bonanno; Orazio Schillaci
Journal:  J Clin Med       Date:  2019-10-11       Impact factor: 4.241

Review 6.  DOK7 Inhibits Cell Proliferation, Migration, and Invasion of Breast Cancer via the PI3K/PTEN/AKT Pathway.

Authors:  Changli Yue; Yuping Bai; Yingshi Piao; Honggang Liu
Journal:  J Oncol       Date:  2021-01-22       Impact factor: 4.375

7.  A seven-nuclear receptor-based prognostic signature in breast cancer.

Authors:  F Wu; W Chen; X Kang; L Jin; J Bai; H Zhang; X Zhang
Journal:  Clin Transl Oncol       Date:  2020-11-18       Impact factor: 3.405

8.  Increased SIX-1 expression promotes breast cancer metastasis by regulating lncATB-miR-200s-ZEB1 axis.

Authors:  Lizhe Zhu; Siyuan Jiang; Shibo Yu; Xiaoxu Liu; Shengyu Pu; Peiling Xie; Heyan Chen; Xiaoqin Liao; Ke Wang; Bin Wang
Journal:  J Cell Mol Med       Date:  2020-03-30       Impact factor: 5.310

Review 9.  Perspectives on the Role of Histone Modification in Breast Cancer Progression and the Advanced Technological Tools to Study Epigenetic Determinants of Metastasis.

Authors:  Jialang Zhuang; Qin Huo; Fan Yang; Ni Xie
Journal:  Front Genet       Date:  2020-10-29       Impact factor: 4.599

10.  Microscopic Tumour Classification by Digital Mammography.

Authors:  Jingjing Yang; Huichao Li; Ning Shi; Qifan Zhang; Yanan Liu
Journal:  J Healthc Eng       Date:  2021-02-04       Impact factor: 2.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.